Teva Pharmaceutical Industries Limited

Last price update: 12 Dec 24 23:00 GMT

Price:
$16.81
Open:
$17.50
Previous close:
$17.45
Day's range:
$16.79 - $17.72
Year's range:
$9.90 - $19.31
Net Income per Share:
-0.85
Price-to-Earnings ratio:
-19.78
52-week Price Range:
$17.54
Volume:
$6,497,761.00
Average volume:
$6,708,796.00

Company profile for Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited logo

Teva Pharmaceutical Industries Limited is a leading global pharmaceutical company that develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products worldwide. They have a wide range of products in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. They are particularly focused on developing products in the central nervous system, pain, respiratory, and oncology areas. Their products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis, AJOVY for the preventive treatment of migraine, and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. Their respiratory products comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Their oncology products include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration with MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia.

Teva Pharmaceutical Industries Limited has a long and successful history, having been founded in 1901 in Tel Aviv-Yafo, Israel. Since then, the company has grown to become one of the leading global pharmaceutical companies, with operations in over 60 countries and over 45,000 employees worldwide. It is the world’s largest generic drug maker and one of the world’s leading providers of specialty and biopharmaceutical products. In 2019, Teva had revenue of over $19 billion, with a focus on providing access to quality and affordable medicines to millions of people around the world. Teva is committed to making a positive impact on global health, and is a signatory of the United Nations Global Compact, a corporate sustainability initiative. The company also strives to be a responsible corporate citizen, and is committed to responsible environmental practices, responsible business practices, and giving back to the communities in which it operates.

Stock exchanges:
NYSE
Sector:
Healthcare
Industries:
Drug Manufacturers
Ticker:
TEVA
CIK:
818686
ISIN:
US8816242098
Website:
https://www.tevapharm.com
Phone:
972 3 914 8213
Origin:
Israel
Employees:
34,713